Astellas Pharma (Verekitug Asthma Drug) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Astellas Pharma (Verekitug Asthma Drug) General Information
Description
An asthma drug. The asset is a novel recombinant fully human immunoglobulin monoclonal antibody that binds to the thymic stromal lymphopoietin receptor and inhibits its signaling
Contact Information
Corporate Office
- Tokyo
- Japan
Corporate Office
- Tokyo
- Japan
Astellas Pharma (Verekitug Asthma Drug) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Astellas Pharma (Verekitug Asthma Drug) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Astellas Pharma (Verekitug Asthma Drug) FAQs
-
Where is Astellas Pharma (Verekitug Asthma Drug) headquartered?
Astellas Pharma (Verekitug Asthma Drug) is headquartered in Tokyo, Japan.
-
What industry is Astellas Pharma (Verekitug Asthma Drug) in?
Astellas Pharma (Verekitug Asthma Drug)’s primary industry is Buildings and Property.
-
Is Astellas Pharma (Verekitug Asthma Drug) a private or public company?
Astellas Pharma (Verekitug Asthma Drug) is a Private company.
-
What is Astellas Pharma (Verekitug Asthma Drug)’s current revenue?
The current revenue for Astellas Pharma (Verekitug Asthma Drug) is .
-
Who are Astellas Pharma (Verekitug Asthma Drug)’s investors?
Astellas Pharma has invested in Astellas Pharma (Verekitug Asthma Drug).
-
When was Astellas Pharma (Verekitug Asthma Drug) acquired?
Astellas Pharma (Verekitug Asthma Drug) was acquired on 01-Oct-2021.
-
Who acquired Astellas Pharma (Verekitug Asthma Drug)?
Astellas Pharma (Verekitug Asthma Drug) was acquired by Upstream Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process